Summit on Cancer Health Disparities (SCHD24)

Seattle, WA US
April 26, 2024 to April 28, 2024

This annual oncology conference, The Summit on Cancer Health Disparities (SCHD24), is one of the largest gatherings of cancer care professionals interested in cancer health disparities with a focus on achieving health equity. This year SCHD 2024 will feature lectures, panel discussions, and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss factors leading to cancer health disparities. A focus of the conference is to explore how these factors can be mitigated to optimize the outcomes of cancer patients. A distinctive feature of this conference is case-based discussions that will describe a problem, how it was solved, and the lessons learned.

SCHD 2024 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.

Target Audience

  • Oncologists
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Pharmacists
  • Fellows/Residents
  • Researchers
  • Others interested in cancer disparities

Organizing Committee 

Program Director:

Dr. Binay Shah - Binaytara Foundation

Conference Co-Chairs:

Dr. Ana María López - Sidney Kimmel Cancer Center, Thomas Jefferson University

Dr. David Aboulafia - Virginia Mason Medical Center

Dr. Hannah Linden - University of Washington and Fred Hutchinson Cancer Center

Organizing Committee:

Dr. Martha Pritchett Mims - Baylor College of Medicine

Dr. Jorge Cortes - Georgia Cancer Center at Augusta University

Dr. Kamran Mirza - Loyola Pathology

Dr. Ishwaria Subbiah - Sarah Cannon Research Institute

Dr. Siddhartha Yadav - Mayo Clinic

Dr. Kashyap Patel - Carolina Blood and Cancer Care Associates

Dr. Dan Milner - Union for International Cancer Control

Abstract Committee Co-Chairs:

Dr. Martha Pritchett Mims - Baylor College of Medicine

Dr. Siddhartha Yadav - Mayo Clinic

Abstract Committee:

Dr. Ronan Hsieh - University of Washington and Fred Hutchinson Cancer Center

Dr. Srinivas Tantravahi - University of Utah Huntsman Cancer Institute

Dr. Manisha Bhattacharya - University of Pittsburgh Medical Center

Dr. Kamran Mirza - Loyola Pathology

Dr. Gregory Vidal - West Cancer Center

Dr. Aparna Parikh - Massachusetts General Hospital

Dr. Ursa Brown-Glaberman - University of New Mexico Comprehensive Cancer Center

Dr. Darya Kizub - MD Anderson Cancer Center

Media and Publications Committee Co-Chairs

Dr. Ishwaria Subbiah - Sarah Cannon Research Institute

Dr. Kamran Mirza - Loyola Pathology

Dr. Umang Swami - University of Utah Huntsman Cancer Institute

Sponsorship Committee Chair:

Dr. Fengting Yan - Swedish Cancer Institute

HOTEL RESERVATION

Attendees and supporters of this meeting can book their hotel room at the Grand Hyatt Seattle at the discounted rate of $209/night + applicable taxes and fees. This rate is based on single occupancy and is valid three days before/after the meeting. The "Cut-Off Date" is 04 April 2024. 

Click here to book your hotel room a the discounted rate.

Abstract Submission

Submit abstracts to present at the 2024 Summit on Cancer Health Disparities

 

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  1. Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
  2. Review barriers to using multidisciplinary cancer care and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.
  3. Discuss newer technologies and their impact on cancer health disparities. 
  4. Review the effectiveness of various interventional approaches and incorporate evidence-based strategies to minimize cancer health disparities in specific populations.
  5. Describe challenges and develop novel approaches, including technology utilization, to improve underrepresented communities' participation in clinical trials.
  6. Discuss the role of government policies and health care legislation in cancer health disparities and policy changes needed to improve access to cancer care.

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Course opens: 
09/20/2023
Course expires: 
07/30/2024
Event starts: 
04/26/2024 - 8:00am PDT
Event ends: 
04/28/2024 - 4:00pm PDT
Cost:
$450.00

APRIL 26, 2024

All times are listed in Pacific Time (PT)


08:00 – 08:15 AM: Welcome 


08:15 – 09:30 AM: SESSION I: UNDERSTANDING DISPARITIES

Session Co-Chairs: David Aboulafia, MD and Gita Suneja, MD, MS

08:15 – 08:35 AM: Keynote speech 

08:35 – 09:05 AM: Two case-based presentations (problem description, how it was solved, and the lessons learned)

09:05 – 09:30 AM: Panel discussion


09:30 – 10:00 AM: BREAK


10:00 – 11:30 AM: SESSION II: DISEASE SPECIFIC DISPARITIES 

Session Co-Chairs: Mark Pegram, MD and Kamran M. Mirza, MD, PhD

10:00 – 10:15 AM: Lung cancer - Nicholas P. Giustini, MD

10:15 – 10:30 AM: GI cancer 

10:30 – 10:45 AM: GU cancer - Ulka Vaishampayan, MD

10:45 – 11:00 AM: Hematologic malignancies - Irum Khan, MD

11:00 – 11:15 AM: Breast cancer 

11:15 – 11:30 AM: Panel discussion 


11:30 AM – 12:15 PM: SESSION III: CARING FOR THE CARERS: DIVERSITY, INCLUSION, AND PROFESSIONAL WELL-BEING OF THE GLOBAL COMMUNITY OF CANCER CARE PROFESSIONALS

11:30 – 11:50 AM: Keynote speech - Ishwaria Subbiah, MD, MS

11:50 AM – 12:15 PM: Panel discussion     


12:15 – 01:15 PM: LUNCH


01:15 – 2:30 PM: SESSION IV: INTEGRATION OF TECHNOLOGY INTO CANCER CARE 

Session Chair: Manish Kohli, MD

01:15 – 01:35 PM: Keynote speech - Joseph Finkelstein, MD, PhD, FAMIA, FACMI

01:35 – 02:05 PM: Two case-based presentations (problem description, how it was solved, and the lessons learned)

02:05 – 02:30 PM: Panel discussion


02:30 – 02:45 PM: BREAK


02:45 – 04:15 PM: SESSION V: ACHIEVING QUALITY THROUGH VALUE-BASED MODELS FOR CANCER CARE: PRACTICAL SOLUTIONS

Session Chair: Ana María López, MD, MPH, MACP

02:45 – 03:05 PM: Keynote speech - Stephen S. Grubbs, MD, FASCO

03:05 – 03:50 PM: Three case-based presentations (problem description, how it was solved, and the lessons learned)

03:50 – 04:15 PM: Panel discussion - Barbara L. McAneny, MD


04:15 – 05:30 PM: RECEPTION AND NETWORKING


APRIL 27, 2024


08:00 – 09:30 AM: SESSION VI: COMMUNITY ENGAGEMENT

Session Chair: Martha Pritchett Mims, MD, PhD

08:00 – 08:20 AM: Keynote speech - Amelie G. Ramirez, DrPH, MPH

08:20 – 09:05 AM: Three case-based presentations (problem description, how it was solved, and the lessons learned)

09:05 – 09:30 AM: Panel discussion 


09:30 – 10:00 AM: BREAK


10:00 – 11:00 AM: SESSION VII: DRUG SHORTAGE

Session Chair: Hannah M. Linden, MD, FACP

10:00 – 10:20 AM: Keynote speech

10:20 – 10:50 AM: Two case-based presentations (problem description, how it was solved, and the lessons learned)

10:50 – 11:00 AM: Panel discussion  


11:00 AM – 12:00 PM: SESSION VIII: ONCOLOGY LEADERS’ APPROACH TO CANCER HEALTH DISPARITIES

Panelists: Margaret Foti, PhD, MD (hc); Edith P. Mitchell, MD, FACP


12:00 – 01:00 PM: LUNCH 


01:00 – 02:30 PM: SESSION IX: CLINICAL TRIALS AND RESEARCH DIVERSITY 

Session Chair: Jorge E. Cortes, MD

01:00 – 01:20 PM: Keynote speech 

01:20 – 02:05 PM: Three case-based presentations (problem description, how it was solved, and the lessons learned)  

02:05 – 02:30 PM: Panel discussion 


02:30 – 02:45 PM: BREAK


02:45 – 04:15 PM: SESSION X: GLOBAL ONCOLOGY

Session Co-Chairs: Siddhartha Yadav, MBBS and Dan A. Milner, Jr., MD, MSc(EPi), FASCP

02:45 – 03:05 PM: Keynote speech - Binay Shah, MD, MHA

03:05 – 03:50 PM: Three case-based presentations (problem description, how it was solved, and the lessons learned)

New Approaches to Improving Access to Resource-Appropriate Immunotherapy for the Prevention and Treatment of Cancer - Corey Casper, MD, MPH

03:50 – 04:15 PM: Panel discussion - Yogendra P. Singh, MBBS, MD; Regine Nshimiyimana Maniraho, DNP, BPharm, FNP, AGACNP, AOCNP


06:00 - 08:30 PM: BINAYTARA FOUNDATION GALA DINNER


APRIL 28, 2024


08:45 – 10:15 AM: SESSION XI: DEBATE: IS UNIVERSAL HEALTHCARE A SOLUTION TO U.S. HEALTHCARE DISPARITIES?

Panelists: Karen E. Knudsen, MBA, PhD


10:15 – 10:30 AM: BREAK


10:30 AM – 12:00 PM: SESSION XII: ABSTRACT SESSION

Session Co-Chairs: Martha Pritchett Mims, MD, PhD and Siddhartha Yadav, MBBS


12:00 PM: ADJOURN

 

Grand Hyatt Seattle
721 Pine St
Seattle, WA 98101
United States

Attendees and supporters of this meeting can book their hotel room at the Grand Hyatt Seattle at the discounted rate of $209/night + applicable taxes and fees. This rate is based on single occupancy and is valid three days before/after the meeting. The "Cut-Off Date" is 04 April 2024. 

 

 

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Session Chair(s)

Manish Kohli

has a financial relationship (Professional Services) with Tempus Inc;.
has a financial relationship (Professional Services) with Janssen Scientific Affairs, LLC;.
has a financial relationship (Travel) with Apollo Hospital Enterprise Limited;.
has a financial relationship (Travel) with Triomics;.

Martha Mims

has a financial relationship (Grant Or Contract) with Celgene;.
has a financial relationship (Stock) with Biogen IDEC;.
has a financial relationship (Stock) with Amgen;.
has a financial relationship (Grant Or Contract) with Incyte;.
has a financial relationship (Grant Or Contract) with Aveo;.

Kamran Mirza, MD PhD

has a financial relationship (Independent contractor) with Astellas Pharma;.
Speaker/Topic Presenter(s)

Karen Knudsen, MBA, PhD

has no relevant financial relationships to disclose at this time.

Ulka Vaishampayan, MD

has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with sanofi;.
has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with Bayer;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Exelixis;.
has a financial relationship (Professional Services) with Gilead;.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$450.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

The registration fee for employees of companies not supporting this meeting is $1500. If your company is a supporter of this meeting, please review the prospectus for pricing.

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot, or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including any pleasantries, introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.